LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 256

Search options

  1. Article ; Online: Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1.

    Metry, Elisabeth L / Garrelfs, Sander F / Peters-Sengers, Hessel / Vaz, Frederic M / Bijlsma, Joost A / Neradova, Aegida / Oosterveld, Michiel J S / Groothoff, Jaap W

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

    2023  Volume 38, Issue 7, Page(s) 1773–1775

    MeSH term(s) Humans ; Oxalates ; Renal Dialysis ; Hyperoxaluria, Primary ; Glycolates ; Hyperoxaluria
    Chemical Substances Oxalates ; glycolic acid (0WT12SX38S) ; Glycolates
    Language English
    Publishing date 2023-03-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 90594-x
    ISSN 1460-2385 ; 0931-0509
    ISSN (online) 1460-2385
    ISSN 0931-0509
    DOI 10.1093/ndt/gfad049
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Ophthalmic acid is a glutathione regulating tripeptide.

    Schomakers, Bauke V / Jillings, Sonia L / van Weeghel, Michel / Vaz, Frédéric M / Salomons, Gajja S / Janssens, Georges E / Houtkooper, Riekelt H

    The FEBS journal

    2024  

    Abstract: Since its discovery in 1958 in the lens of cows, ophthalmic acid (OPH) has stood in the shadow of its anti-oxidant analog: glutathione (GSH). Lacking the thiol group that gives GSH many of its important properties, ophthalmic acid's function has remained ...

    Abstract Since its discovery in 1958 in the lens of cows, ophthalmic acid (OPH) has stood in the shadow of its anti-oxidant analog: glutathione (GSH). Lacking the thiol group that gives GSH many of its important properties, ophthalmic acid's function has remained elusive, and it has been widely presumed to be an accidental product of the same enzymes. In this review, we compile evidence demonstrating that OPH is a ubiquitous metabolite found in bacteria, plants, fungi, and animals, produced through several layers of metabolic regulation. We discuss the limitations of the oft-repeated suggestions that aberrations in OPH levels should solely indicate GSH deficiency or oxidative stress. Finally, we discuss the available literature and suggest OPH's role in metabolism as a GSH-regulating tripeptide; controlling both cellular and organelle influx and efflux of GSH, as well as modulating GSH-dependent reactions and signaling. Ultimately, we hope that this review reinvigorates and directs more research into this versatile metabolite.
    Language English
    Publishing date 2024-01-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2173655-8
    ISSN 1742-4658 ; 1742-464X
    ISSN (online) 1742-4658
    ISSN 1742-464X
    DOI 10.1111/febs.17061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Plasma Lipidomic Profiles in cART-Treated Adolescents with Perinatally Acquired HIV Compared to Matched Controls.

    van der Post, Julie / Guerra, Thiara E J / van den Hof, Malon / Vaz, Frédéric M / Pajkrt, Dasja / van Genderen, Jason G

    Viruses

    2024  Volume 16, Issue 4

    Abstract: Children with perinatally acquired human immunodeficiency virus (PHIV) are growing into adulthood with HIV and treatment-associated comorbidities, such as dyslipidemia and insulin resistance. HIV is identified as independent risk factor for ... ...

    Abstract Children with perinatally acquired human immunodeficiency virus (PHIV) are growing into adulthood with HIV and treatment-associated comorbidities, such as dyslipidemia and insulin resistance. HIV is identified as independent risk factor for cardiovascular disease (CVD). The hypothesis behind increased CVD risk associated with HIV includes vascular inflammation, dyslipidemia and combination antiretroviral therapy (cART) metabolomic toxicity. To investigate differences in lipid profiles and pathophysiological mechanisms of CVD risk in adolescents with PHIV, we compared the plasma lipidome of PHIV adolescents and HIV-negative controls. We additionally investigated the influence of current cART regimens and increased lipoprotein(a) (Lp(a)) levels on the plasma lipidome. We included 20 PHIV-infected adolescents and 20 HIV-negative controls matched for age, sex, ethnic origin and socio-economic status. Plasma lipidome was measured using Thermo Scientific Ultimate 3000 binary high-performance liquid chromatography (HPLC)-mass spectrometry. We evaluated the plasma lipidome in PHIV adolescents using different cART regimens (including those known to be associated with lipid alterations). The median age was 17.5 years (15.5-20.7) and 16.5 years (15.7-19.8) for PHIV adolescents and controls, respectively. Of PHIV adolescents, 45% used a non-nucleotide reverse transcriptase inhibitor (NNRTI)-based (25%) or protease inhibitor (PI)-based (20%) cART regimen. In this pilot study, we observed no significant differences between lipidomic profiles between PHIV adolescents and controls. We observed no differences in the plasma lipidome in participants with increased versus normal Lp(a) levels. Different cART regimens appear to influence chain length differences in the plasma lipidome of PHIV adolescents; however, the significance and causality of this observation remains undetermined. Further research on the influence of cART on lipid composition could further identify these alterations.
    MeSH term(s) Humans ; Adolescent ; HIV Infections/drug therapy ; Female ; Male ; Lipidomics ; Lipids/blood ; Young Adult ; Anti-HIV Agents/therapeutic use ; Case-Control Studies ; Anti-Retroviral Agents/therapeutic use ; Infectious Disease Transmission, Vertical ; Cardiovascular Diseases
    Chemical Substances Lipids ; Anti-HIV Agents ; Anti-Retroviral Agents
    Language English
    Publishing date 2024-04-09
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v16040580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Barth syndrome and the many fascinating aspects of cardiolipin.

    Vaz, Frédéric M / Wanders, Ronald J A / Vernon, Hilary

    Journal of inherited metabolic disease

    2021  Volume 45, Issue 1, Page(s) 1–2

    MeSH term(s) Acyltransferases/genetics ; Barth Syndrome/genetics ; Barth Syndrome/metabolism ; Cardiolipins/metabolism ; Humans
    Chemical Substances Cardiolipins ; Acyltransferases (EC 2.3.-) ; TAFAZZIN protein, human (EC 2.3.1.-)
    Language English
    Publishing date 2021-12-14
    Publishing country United States
    Document type Editorial
    ZDB-ID 438341-2
    ISSN 1573-2665 ; 0141-8955
    ISSN (online) 1573-2665
    ISSN 0141-8955
    DOI 10.1002/jimd.12460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case-control study.

    Gatechompol, Sivaporn / Lutter, René / Vaz, Frédéric M / Ubolyam, Sasiwimol / Avihingsanon, Anchalee / Kerr, Stephen J / van Leth, Frank / Cobelens, Frank

    BMC infectious diseases

    2024  Volume 24, Issue 1, Page(s) 372

    Abstract: Background: Non-sputum-based tests are needed to predict or diagnose tuberculosis (TB) disease in people living with HIV (PWH). The enzyme indoleamine 2, 3-dioxygenase-1 (IDO1) is expressed in tuberculoid granuloma and catabolizes tryptophan (Trp) to ... ...

    Abstract Background: Non-sputum-based tests are needed to predict or diagnose tuberculosis (TB) disease in people living with HIV (PWH). The enzyme indoleamine 2, 3-dioxygenase-1 (IDO1) is expressed in tuberculoid granuloma and catabolizes tryptophan (Trp) to kynurenine (Kyn). IDO1 activity compromises innate and adaptive immune responses, promoting mycobacterial survival. The plasma Kyn-to-Trp (K/T) ratio is a potential TB diagnostic and/or predictive biomarker in PWH on long-term antiretroviral therapy (ART).
    Methods: We compared plasma K/T ratios in samples from PWH, who were followed up prospectively and developed TB disease after ART initiation. Controls were matched for age and duration of ART. Kyn and Trp were measured at 3 timepoints; at TB diagnosis, 6 months before TB diagnosis and 6 months after TB diagnosis, using ultra performance liquid chromatography combined with mass spectrometry.
    Results: The K/T ratios were higher for patients with TB disease at time of diagnosis (median, 0.086; IQR, 0.069-0.123) compared to controls (0.055; IQR 0.045-0.064; p = 0.006), but not before or after TB diagnosis. K/T ratios significantly declined after successful TB treatment, but increased upon treatment failure. The K/T ratios showed a parabolic correlation with CD4 cell counts in participants with TB (p = 0.005), but there was no correlation in controls.
    Conclusions: The plasma K/T ratio helped identify TB disease and may serve as an adjunctive biomarker for for monitoring TB treatment in PWH. Validation studies to ascertain these findings and evaluate the optimum cut-off for diagnosis of TB disease in PWH should be undertaken in well-designed prospective cohorts.
    Trial registration: ClinicalTrials.gov Identifier: NCT00411983.
    MeSH term(s) Humans ; Tryptophan ; Kynurenine ; Prospective Studies ; Case-Control Studies ; HIV Infections/complications ; HIV Infections/drug therapy ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; Biomarkers ; Indoleamine-Pyrrole 2,3,-Dioxygenase
    Chemical Substances Tryptophan (8DUH1N11BX) ; Kynurenine (343-65-7) ; Biomarkers ; Indoleamine-Pyrrole 2,3,-Dioxygenase
    Language English
    Publishing date 2024-04-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041550-3
    ISSN 1471-2334 ; 1471-2334
    ISSN (online) 1471-2334
    ISSN 1471-2334
    DOI 10.1186/s12879-024-09258-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Long-term Efficacy and Safety of Elamipretide in Patients with Barth Syndrome: 168-Week Open-label Extension Results of TAZPOWER.

    Thompson, William R / Manuel, Ryan / Abbruscato, Anthony / Carr, Jim / Campbell, John / Hornby, Brittany / Vaz, Frédéric M / Vernon, Hilary J

    Genetics in medicine : official journal of the American College of Medical Genetics

    2024  , Page(s) 101138

    Abstract: Purpose: Evaluate long-term efficacy and safety of elamipretide during the open-label extension (OLE) of the TAZPOWER trial in individuals with Barth syndrome (BTHS) .: Methods: TAZPOWER was a 28-week randomized, double-blind, placebo-controlled ... ...

    Abstract Purpose: Evaluate long-term efficacy and safety of elamipretide during the open-label extension (OLE) of the TAZPOWER trial in individuals with Barth syndrome (BTHS) .
    Methods: TAZPOWER was a 28-week randomized, double-blind, placebo-controlled trial followed by a 168-week OLE. Patients entering the OLE continued elamipretide 40mg subcutaneous daily. OLE primary endpoints were safety and tolerability; secondary endpoints included change from baseline in the 6-minute walk test (6MWT) and BarTH Syndrome Symptom Assessment (BTHS-SA) Total Fatigue. Muscle strength, physician- and patient-assessed outcomes, echocardiographic parameters, and biomarkers, including cardiolipin (CL) and monolysocardiolipin (MLCL), were assessed.
    Results: Ten patients entered the OLE; 8 reached the Week 168 visit. Elamipretide was well tolerated, with injection site reactions being the most common adverse events. Significant improvements from OLE baseline on 6MWT occurred at all OLE timepoints (cumulative 96.1 meters of improvement [Week 168, p=0.003]). Mean BTHS-SA Total Fatigue scores were below baseline (improved) at all OLE timepoints. 3-D left ventricular stroke, end-diastolic, and end-systolic volumes improved, showing significant trends for improvement from baseline to Week 168. MLCL/CL values showed improvement, correlating to important clinical outcomes.
    Conclusion: Elamipretide was associated with sustained long-term tolerability and efficacy, with improvements in functional assessments and cardiac function in BTHS.
    Language English
    Publishing date 2024-04-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1455352-1
    ISSN 1530-0366 ; 1098-3600
    ISSN (online) 1530-0366
    ISSN 1098-3600
    DOI 10.1016/j.gim.2024.101138
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1.

    Garrelfs, Sander F / Metry, Elisabeth L / van Harskamp, Dewi / Vaz, Frederic M / van den Akker, Chris H P / Schierbeek, Henk / Groothoff, Jaap W / Oosterveld, Michiel J S

    Kidney international

    2023  Volume 103, Issue 5, Page(s) 990–993

    MeSH term(s) Humans ; Hyperoxaluria, Primary/diagnosis ; Hyperoxaluria, Primary/drug therapy ; Hyperoxaluria, Primary/genetics ; Alcohol Oxidoreductases ; Hyperoxaluria ; Oxalates
    Chemical Substances glycollate oxidase (EC 1.1.3.15) ; lumasiran (RZT8C352O1) ; Alcohol Oxidoreductases (EC 1.1.-) ; Oxalates
    Language English
    Publishing date 2023-03-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1016/j.kint.2023.01.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A novel homozygous missense variant in ARSK causes MPS X, a new subtype of mucopolysaccharidosis

    Miao Sun / Cornelia K. Kaminsky / Philip Deppe / Mai-Britt Ilse / Frédéric M. Vaz / Barbara Plecko / Torben Lübke / Linda M. Randolph

    Genes and Diseases, Vol 11, Iss 3, Pp 101025- (2024)

    2024  

    Keywords Medicine (General) ; R5-920 ; Genetics ; QH426-470
    Language English
    Publishing date 2024-05-01T00:00:00Z
    Publisher KeAi Communications Co., Ltd.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.

    Wanders, Ronald J A / Vaz, Frédéric M / Waterham, Hans R / Ferdinandusse, Sacha

    Advances in experimental medicine and biology

    2021  Volume 1299, Page(s) 55–70

    Abstract: Peroxisomes play a central role in metabolism as exemplified by the fact that many genetic disorders in humans have been identified through the years in which there is an impairment in one or more of these peroxisomal functions, in most cases associated ... ...

    Abstract Peroxisomes play a central role in metabolism as exemplified by the fact that many genetic disorders in humans have been identified through the years in which there is an impairment in one or more of these peroxisomal functions, in most cases associated with severe clinical signs and symptoms. One of the key functions of peroxisomes is the β-oxidation of fatty acids which differs from the oxidation of fatty acids in mitochondria in many respects which includes the different substrate specificities of the two organelles. Whereas mitochondria are the main site of oxidation of medium-and long-chain fatty acids, peroxisomes catalyse the β-oxidation of a distinct set of fatty acids, including very-long-chain fatty acids, pristanic acid and the bile acid intermediates di- and trihydroxycholestanoic acid. Peroxisomes require the functional alliance with multiple subcellular organelles to fulfil their role in metabolism. Indeed, peroxisomes require the functional interaction with lysosomes, lipid droplets and the endoplasmic reticulum, since these organelles provide the substrates oxidized in peroxisomes. On the other hand, since peroxisomes lack a citric acid cycle as well as respiratory chain, oxidation of the end-products of peroxisomal fatty acid oxidation notably acetyl-CoA, and different medium-chain acyl-CoAs, to CO
    MeSH term(s) Fatty Acids/metabolism ; Humans ; Lipid Metabolism ; Oxidation-Reduction ; Peroxisomal Disorders/enzymology ; Peroxisomal Disorders/metabolism ; Peroxisomes/enzymology ; Peroxisomes/metabolism
    Chemical Substances Fatty Acids
    Language English
    Publishing date 2021-01-08
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    DOI 10.1007/978-3-030-60204-8_5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Inherited disorders of complex lipid metabolism: A clinical review.

    Xiao, Changrui / Rossignol, Francis / Vaz, Frédéric M / Ferreira, Carlos R

    Journal of inherited metabolic disease

    2021  Volume 44, Issue 4, Page(s) 809–825

    Abstract: Over 80 human diseases have been attributed to defects in complex lipid metabolism. A majority of them have been reported recently in the setting of rapid advances in genomic technology and their increased use in clinical settings. Lipids are ubiquitous ... ...

    Abstract Over 80 human diseases have been attributed to defects in complex lipid metabolism. A majority of them have been reported recently in the setting of rapid advances in genomic technology and their increased use in clinical settings. Lipids are ubiquitous in human biology and play roles in many cellular and intercellular processes. While inborn errors in lipid metabolism can affect every organ system with many examples of genetic heterogeneity and pleiotropy, the clinical manifestations of many of these disorders can be explained based on the disruption of the metabolic pathway involved. In this review, we will discuss the physiological function of major pathways in complex lipid metabolism, including nonlysosomal sphingolipid metabolism, acylceramide metabolism, de novo phospholipid synthesis, phospholipid remodeling, phosphatidylinositol metabolism, mitochondrial cardiolipin synthesis and remodeling, and ether lipid metabolism as well as common clinical phenotypes associated with each.
    MeSH term(s) Cardiolipins/biosynthesis ; Cardiolipins/chemistry ; Homeostasis ; Humans ; Lipid Metabolism ; Lipids/biosynthesis ; Lipids/chemistry ; Metabolic Networks and Pathways/physiology ; Mitochondria/metabolism ; Mitochondria/pathology ; Phenotype ; Phosphatidylinositols/biosynthesis ; Phosphatidylinositols/chemistry ; Phospholipids/biosynthesis ; Phospholipids/chemistry ; Sphingolipids/biosynthesis ; Sphingolipids/chemistry
    Chemical Substances Cardiolipins ; Lipids ; Phosphatidylinositols ; Phospholipids ; Sphingolipids
    Language English
    Publishing date 2021-03-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 438341-2
    ISSN 1573-2665 ; 0141-8955
    ISSN (online) 1573-2665
    ISSN 0141-8955
    DOI 10.1002/jimd.12369
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top